Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesEffects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
The Lancet, 11/09/09
Astrup A et al. – Liraglutide treatment over 20 weeks is well tolerated, induces weight loss, improves certain obesity–related risk factors, and reduces prediabetes.
Related Articles
The safety and efficacy of liraglutide with or without oral antidiabetic drug therapy in type 2 diabetes: an overview of the LEAD 1–5 studies
Diabetes, Obesity and Metabolism, 11/06/09
Relevance Score: 88%
Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue
Diabetes, Obesity and Metabolism, 11/12/09
Relevance Score: 87%
Diabetes Drug Helps Obese Adults Loss Weight
Diabetes News, 10/27/09
Relevance Score: 84%
A Simulation of the Comparative Long-term Effectiveness of Liraglutide and Glimepiride Monotherapies in Patients with Type 2 Diabetes Mellitus
Pharmacotherapy, 10/28/09
Relevance Score: 83%
Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
The Lancet - Early Online Publication, 10/23/09
Relevance Score: 83%
Today in Obesity...keeping you current
Receive free subspecialty "5-minute updates" via email
Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weight
International Journal of Obesity, 11/25/09
The prognostic impact of general and abdominal obesity in peripheral arterial disease
International Journal of Obesity, 11/25/09
Low Levels of Plasma Agmatine in the Metabolic Syndrome
Metabolic Syndrome and Related Disorders, 11/25/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Effects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome
Diabetes Care, 11/25/09
Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weight
International Journal of Obesity, 11/25/09
Assessment of Regional Changes in Skeletal Metabolism Following 3 and 18 Months of Teriparatide Treatment
Journal of Bone and Mineral Research, 11/25/09
Sponsor
Article Search
Sponsor